ICD-10-CM Billable Code

Q97.3

Female with 46, XY karyotype

Clinical Classification Guidelines

Medical Intelligence & Overview

The diagnosis of a female with a 46, XY karyotype refers to individuals who have an identical chromosome pattern to males but are phenotypically female. This condition falls under the ICD-10 code Q97.3, which encompasses disorders related to sex development and chromosomal variations. Such cases often involve complex medical, psychological, and social considerations, requiring multidisciplinary assessment and support. Understanding the underlying genetics, associated features, and potential health implications is essential for proper management and care.

Causes & Symptoms

Clinical Causes: Genetic variations affecting sex chromosome development De novo mutations during gametogenesis Disorders of sex development (DSD) due to gonadal or hormonal anomalies Swyer syndrome, where individuals have XY chromosomes but develop as females Androgen insensitivity syndrome, where the body's cells can't respond to male hormones Mosaicism involving XY and XX cell lines

Key Symptoms: Feminine physical appearance and secondary sexual characteristics Underdeveloped or absent internal reproductive organs such as the uterus and ovaries Presence of testes or streak gonads within the gonadal tissue Hormonal imbalances, often with elevated androgens or other sex hormones Potential ambiguity in sexual development during fetal growth Psychological and social challenges related to gender identity and societal expectations

Diagnostic & Treatment

Diagnosis Path: Diagnosing a female with 46, XY karyotype typically involves a combination of clinical evaluation and laboratory testing. This includes detailed physical examinations, hormonal profiling, ultrasound imaging of reproductive organs, and karyotype analysis through chromosomal testing. Sometimes, additional genetic testing such as FISH (fluorescence in situ hybridization) or PCR (polymerase chain reaction) is employed to identify specific genetic variants or mosaicism. An interdisciplinary team, including endocrinologists, geneticists, and psychologists, collaborates for an accurate diagnosis and comprehensive assessment.

Treatment Protocols: Management of individuals with a 46, XY karyotype within a female phenotype should be personalized, focusing on physical, hormonal, and psychological needs. Treatment options may include hormone therapy to develop secondary sexual characteristics, surgical interventions to address gonadal or reproductive organ anomalies, and psychological support to assist with gender identity and social integration. Regular monitoring of hormone levels, reproductive health, and cancer screening of gonadal tissue are also important components of ongoing care. A multidisciplinary approach ensures optimal health outcomes and quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q97.3 a billable ICD-10 code?
Yes, Q97.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q97.3?
Clinical documentation must specify the nature of Female with 46, XY karyotype and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

karyotype female